Newswise,
March 14, 2016 — The blueberry, already labeled a
“super fruit” for its power to potentially lower the risk of heart disease and
cancer, also could be another weapon in the war against Alzheimer’s disease.
New research being presented today further bolsters this idea, which is being
tested by many teams.
The
fruit is loaded with healthful antioxidants, and these substances could help
prevent the devastating effects of this increasingly common form of dementia,
scientists report.
The
researchers present their work today at the 251st National Meeting &
Exposition of the American Chemical Society (ACS). ACS, the world’s largest
scientific society, is holding the meeting here through Thursday.
It
features more than 12,500 presentations on a wide range of science topics.
“Our
new findings corroborate those of previous animal studies and preliminary human
studies, adding further support to the notion that blueberries can have a real
benefit in improving memory and cognitive function in some older adults,” says
Robert Krikorian, Ph.D., leader of the research team. He adds that blueberries’
beneficial effects could be due to flavonoids called anthocyanins, which have
been shown to improve animals’ cognition.
Currently
5.3 million people suffer from Alzheimer’s disease. But that number is expected
to increase, Krikorian notes, as the U.S. population ages.
By
2025, the number of Americans with this degenerative disorder could rise 40
percent to more than 7 million, and it could almost triple by 2050, according
to the Alzheimer’s Association.
In
an effort to find ways to slow down this alarming trend, Krikorian and
colleagues at University of Cincinnati Academic Health Center conducted two
human studies to follow up on earlier clinical trials.
One
study involved 47 adults aged 68 and older, who had mild cognitive impairment,
a risk condition for Alzheimer’s disease. The researchers gave them either
freeze-dried blueberry powder, which is equivalent to a cup of berries, or a
placebo powder once a day for 16 weeks.
“There
was improvement in cognitive performance and brain function in those who had
the blueberry powder compared with those who took the placebo,” Krikorian says.
“The
blueberry group demonstrated improved memory and improved access to words and
concepts.”
The
team also conducted functional magnetic resonance imaging (fMRI), which showed
increased brain activity in those who ingested the blueberry powder.
The
second study included 94 people aged 62 to 80, who were divided into four
groups. The participants didn’t have objectively measured cognitive issues, but
they subjectively felt their memories were declining. The groups received
blueberry powder, fish oil, fish oil and powder or placebo.
“The
results were not as robust as with the first study,” Krikorian explained.
“Cognition was somewhat better for those with powder or fish oil separately,
but there was little improvement with memory.”
Also,
fMRI results also were not as striking for those receiving blueberry powder. He
says that the effect may have been smaller in this case because these
participants had less severe issues when they entered the study.
Krikorian
said the two studies indicate that blueberries may be more effective in
treating patients with cognitive impairments, but may not show measurable
benefit for those with minor memory issues or who have not yet developed
cognitive problems.
In
the future, the team plans to conduct a blueberry study with a younger group of
people, aged 50 to 65. The group would include people at risk of developing
Alzheimer’s, such as those who are obese, have high blood pressure or high
cholesterol. This work could help the researchers determine if blueberries could
help prevent the onset of Alzheimer’s symptoms.
He
acknowledges funding from the U.S.
Highbush Blueberry Council, the National Institute on Aging and Wild Blueberries of North
America.
American
Chemical Society is a nonprofit organization chartered by the U.S. Congress.
With
more than 158,000 members, ACS is the world’s largest scientific society and a
global leader in providing access to chemistry-related research through its
multiple databases, peer-reviewed journals and scientific conferences. Its main
offices are in Washington, D.C., and Columbus, Ohio.
No comments:
Post a Comment